Range Cancer Therapeutics ETF (CNCR)

Overview News Price History Discussions Forecast Dividend History

Range Cancer Therapeutics ETF Stock (CNCR) Dividend Overview

Range Cancer Therapeutics ETF (CNCR) currently pays a dividend of $1.8533 per share with annual dividend yield of 12.16% and price-to-earnings ratio of -.
Range Cancer Therapeutics ETF (CNCR) pays out a dividend one time per year. Annually payment frequency should be carefully considered as it can affect investors’ investment strategy.
Range Cancer Therapeutics ETF (CNCR) most recent ex-dividend date occurred on December 29, 2021 with dividend payment of $1.8533 per share received on December 31, 2021. Shareholders eligible for this dividend payment owned CNCR stock before or on this ex-dividend date.

Ex-dividend date

12/29/2021

Annual Dividend

$1.8533

Dividend Yield

12.16%

P/E Ratio

Range Cancer Therapeutics ETF Stock (CNCR) Dividend History

Table below shows the detailed dividend history of Range Cancer Therapeutics ETF Stock (CNCR). In 2024, CNCR hasn’t paid out any dividend. We recommend investors to review previous dividend dates and payments carefully with the aim to gain insights on the company’s strategy and potential dividend payments in the future.

Ex/EFF Date	Type	Cash amount	Declaration date	Record date	Payment date
12/29/2021	CD	$1.8533	12/28/2021	12/30/2021	12/31/2021
12/30/2020	CD	$0.2881	12/29/2020	12/31/2020	01/04/2021
12/28/2017	CD	$0.3502	12/27/2017	12/29/2017	01/02/2018
12/29/2015	CD	$0.1055	12/28/2015	12/31/2015	01/04/2016